Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 7:12:3137-3167.
doi: 10.2147/IDR.S219755. eCollection 2019.

Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment

Reza Ranjbar  1 , Abbas Farahani  1
Affiliations

Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment

Reza Ranjbar et al. Infect Drug Resist. .

Abstract

Shigella spp. are a common cause of diarrheal disease and have remained an important pathogen responsible for increased rates of morbidity and mortality caused by dysentery each year around the globe. Antibiotic treatment of Shigella infections plays an essential role in reducing prevalence and death rates of the disease. However, treatment of these infections remains a challenge, due to the global rise in broad-spectrum resistance to many antibiotics. Drug resistance in Shigella spp. can result from many mechanisms, such as decrease in cellular permeability, extrusion of drugs by active efflux pumps, and overexpression of drug-modifying and -inactivating enzymes or target modification by mutation. Therefore, there is an increasing need for identification and evolution of alternative therapeutic strategies presenting innovative avenues against Shigella infections, as well as paying further attention to this infection. The current review focuses on various antibiotic-resistance mechanisms of Shigella spp. with a particular emphasis on epidemiology and new mechanisms of resistance and their acquisition, and also discusses the status of novel strategies for treatment of Shigella infection and vaccine candidates currently under evaluation in preclinical or clinical phases.

Keywords: Shigella; antibiotics; biofilm; drug resistance; efflux pumps; mechanism; prevention; resistance; treatment; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Schematic representation of blaCTX-M-55, blaCTX-M-15, and blaTEM-1 genes in different types of plasmid. Arrows indicate positions and directions of different genes and IRL, terminal inverted repeats at the left, IRR, terminal inverted repeats at the right.
Figure 2
Figure 2
Physical map of Shigella atypical class 1 integron and locations of blaOXA-30 and aadA genes.
Figure 3
Figure 3
Structure of genes surrounding mcr-1 in S. flexneri.
Figure 4
Figure 4
Variable regions of class 1 (A) and class 2 (B) integrons reported in different geographic area. Horizontal arrows indicate transcriptional orientation of genes.
See this image and copyright information in PMC

References

    1. Kahsay AG, Muthupandian S. A review on sero diversity and antimicrobial resistance patterns of Shigella species in Africa, Asia and South America, 2001–2014. BMC Res Notes. 2016;9(1):422. doi:10.1186/s13104-016-2236-7 - DOI - PMC - PubMed
    1. Puzari M, Sharma M, Chetia P. Emergence of antibiotic resistant Shigella species: a matter of concern. J Infect Public Health. 2018;11(4):451–454. doi:10.1016/j.jiph.2017.09.025 - DOI - PubMed
    1. Qu F, Bao C, Chen S, et al. Genotypes and antimicrobial profiles of Shigella sonnei isolates from diarrheal patients circulating in Beijing between 2002 and 2007. Diagn Microbiol Infect Dis. 2012;74(2):166–170. doi:10.1016/j.diagmicrobio.2012.06.026 - DOI - PMC - PubMed
    1. Organization WH. Antimicrobial Resistance: Global Report on Surveillance. World Health Organization; 2014.
    1. Grimont F, Lejay-Collin M, Talukder KA, et al. Identification of a group of shigella-like isolates as Shigella boydii 20. J Med Microbiol. 2007;56(6):749–754. doi:10.1099/jmm.0.46818-0 - DOI - PubMed